Last 28 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.60 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.73 | 4.88 | 9.16 | 12.62 | 17.26 | 27.17 | 28.40 | 36.08 | 29.40 | 39.44 | 55.39 | 38.37 | 37.81 | 83.05 | 32.51 | 45.36 | 61.49 | 67.02 | 78.13 | 140.51 | — |
| — | -82.0% | -67.7% | -65.0% | -41.3% | -31.1% | -48.7% | -6.0% | -22.2% | -52.5% | +70.4% | -15.4% | -38.5% | +23.9% | -58.4% | -67.7% | — | — | — | — | — | |
| P/B Ratio | 0.32 | 1.12 | 1.25 | 1.34 | 1.52 | 2.02 | 1.80 | 2.29 | 2.17 | 2.43 | 3.06 | 1.88 | 1.86 | 4.43 | 1.54 | 1.79 | 2.42 | 2.25 | 2.04 | 2.51 | 5.17 |
| — | -44.6% | -30.7% | -41.3% | -30.2% | -16.9% | -41.0% | +21.7% | +17.2% | -45.1% | +98.7% | +5.4% | -23.3% | +97.1% | -24.5% | -28.8% | -53.2% | -68.1% | -76.3% | -72.4% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 7.29 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -98.2% | -1050.9% | -62.6% | -97.3% | -83.6% | -106.6% | -108.3% | -96.3% | -92.8% | -105.7% | -84.3% | -71.6% | -67.0% | -65.5% | -62.2% | -81.9% | -59.8% | -79.8% | -106.1% | -116.0% | — |
| — | -886.0% | +42.2% | -1.0% | +9.9% | -0.8% | -28.6% | -34.6% | -38.4% | -61.4% | -35.4% | +12.6% | -12.0% | +17.9% | +41.4% | +29.3% | — | — | — | — | — | |
| Operating Margin | -466.2% | -1334.9% | -343.1% | -480.9% | -413.0% | -476.7% | -500.5% | -499.2% | -466.5% | -537.5% | -512.5% | -553.0% | -887.2% | -690.6% | -493.6% | 430.4% | -813.3% | -1008.3% | -1213.6% | -1680.6% | — |
| — | -180.0% | +31.5% | +3.7% | +11.5% | +11.3% | +2.3% | +9.7% | +47.4% | +22.2% | -3.8% | -228.5% | -9.1% | +31.5% | +59.3% | +125.6% | — | — | — | — | — | |
| Net Margin | -576.1% | -1335.1% | -330.9% | -897.4% | -397.0% | -484.3% | -470.3% | -468.7% | -450.0% | -503.0% | -479.5% | -427.5% | -863.4% | -672.5% | -480.6% | -2103.0% | -784.5% | -891.5% | -1198.3% | -1689.8% | — |
| — | -175.7% | +29.6% | -91.5% | +11.8% | +3.7% | +1.9% | -9.6% | +47.9% | +25.2% | +0.2% | +79.7% | -10.1% | +24.6% | +59.9% | -24.5% | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -45.6% | -55.8% | -10.7% | -22.5% | -8.5% | -8.6% | -7.2% | -8.0% | -8.0% | -7.5% | -6.4% | -5.2% | -10.8% | -8.7% | -5.6% | -19.3% | -7.5% | -7.3% | -7.6% | -8.8% | -6.3% |
| — | -546.0% | -48.4% | -182.6% | -6.2% | -14.6% | -12.3% | -54.5% | +25.6% | +13.1% | -15.8% | +73.3% | -44.3% | -19.3% | +27.0% | -119.2% | -18.4% | -18.5% | -36.5% | -9.1% | +20.0% | |
| ROA | -40.3% | -46.8% | -9.3% | -19.7% | -7.6% | -7.7% | -6.5% | -7.1% | -7.2% | -6.8% | -5.8% | -4.6% | -9.4% | -7.5% | -4.8% | -16.0% | -6.1% | -5.9% | -6.1% | -7.6% | -6.1% |
| — | -506.0% | -42.3% | -176.4% | -5.7% | -14.3% | -12.9% | -56.7% | +23.4% | +9.7% | -20.8% | +71.6% | -52.9% | -26.9% | +21.8% | -111.3% | -0.6% | -1.7% | -15.3% | +3.7% | +20.2% | |
| ROIC | -35.6% | -59.8% | -11.8% | -12.3% | -8.9% | -8.2% | -7.0% | -7.7% | -7.6% | -7.5% | -6.6% | -6.9% | -11.1% | -8.1% | -5.1% | 3.5% | -6.9% | -7.5% | -7.2% | -9.0% | -8.5% |
| — | -630.7% | -67.8% | -59.4% | -15.9% | -9.7% | -5.6% | -12.4% | +30.9% | +8.0% | -30.8% | -297.3% | -59.3% | -8.0% | +29.2% | +138.8% | +18.7% | +59.6% | +90.1% | +94.1% | +99.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.06 | 0.11 | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| — | +119.3% | +44.8% | +42.7% | +5.5% | +10.4% | -4.0% | -8.3% | +54.3% | +83.1% | +83.1% | +101.4% | +55.7% | +22.3% | +14.1% | +7.9% | -1.1% | +208.5% | +206.6% | +216.2% | +457.1% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.38 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.96 | 2.84 | 3.64 | 3.96 | 4.14 | 4.19 | 5.30 | 5.63 | 4.64 | 5.16 | 5.81 | 5.71 | 4.87 | 3.31 | 3.39 | 3.29 | 2.08 | 2.21 | 1.53 | 1.80 | 17.96 |
| — | -32.2% | -31.4% | -29.8% | -10.7% | -18.7% | -8.8% | -1.4% | -4.8% | +55.9% | +71.5% | +73.6% | +134.4% | +49.7% | +121.3% | +82.9% | -88.4% | -92.4% | -87.4% | -96.3% | -55.3% | |
| Quick Ratio | 3.77 | 2.59 | 3.40 | 3.77 | 3.93 | 4.03 | 5.16 | 5.52 | 4.56 | 5.09 | 5.59 | 5.56 | 4.86 | 3.27 | 3.32 | 3.19 | 2.08 | 2.19 | 1.49 | 1.74 | 17.96 |
| — | -35.6% | -34.0% | -31.7% | -13.9% | -20.8% | -7.7% | -0.6% | -6.2% | +55.6% | +68.1% | +74.1% | +134.1% | +49.3% | +123.2% | +83.6% | -88.4% | -92.4% | -87.7% | -96.5% | -55.3% | |
| Interest Coverage | — | — | — | — | — | -97.26 | — | — | — | — | — | — | — | — | — | -232.65 | — | — | — | -130.45 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 28 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NNOX stock.
Nano-X Imaging Ltd.'s current P/E is -0.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Nano-X Imaging Ltd.'s current operating margin is -466.2%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Nano-X Imaging Ltd.'s business trajectory between earnings reports.